Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T13:35:27.668Z.
Consensus retrieved: 2026-10-06T08:44:49.600Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T13:35:27.668Z.
Quote observation: 2026-10-06T13:34:57.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fdfad12185ff1a6c55ef1236bc2340ccae7aa6e4dec3824b1e7761c8ffaeec30
Forward PE Ratio (N/A) = Dated Quote Price ($6.03) / Consensus Forward EPS ($-0.01)
FORWARD PE RATIO
N/A
Alvotech
Market Cap
$2.04B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Alvotech (ALVO) | $2.04B | N/A |
| Azenta, Inc. (AZTA)vs › | $2.05B | 89.38 |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.05B | N/A |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 16.66 |
| AxoGen, Inc. (AXGN)vs › | $2.02B | 84.81 |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.07B | 59.90 |
| Absci Corporation (ABSI)vs › | $1.99B | N/A |
| Immunome, Inc. (IMNM)vs › | $1.99B | N/A |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.99B | N/A |
| Addus HomeCare Corporation (ADUS)vs › | $2.12B | 16.16 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $6.03, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-0.01 | $-0.05 – $0.01 | 3 | n/m |
| 2027-12-31 | $0.23 | $0.17 – $0.28 | 4 | 26.0x |
| 2028-12-31 | $0.45 | $0.14 – $0.90 | 3 | 13.4x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
